Search | TVST | ARVO Journals

Showing 1 – 20 of 51

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Association between diabetic macular edema and mortality independent of retinopathy (R) grade - The North East London Diabetic Eye Screening Programme (DESP) Study

Abraham Olvera-Barrios; Christopher G Owen; John Anderson; Ryan Chambers; Louis Bolter; Alasdair Warwick; Yue Wu; Roshan Welikala; Jiri Fajtl; Sarah Barman; Emily Y. Chew; Frederick L Ferris; Aaron Y Lee; Adnan Tufail; Catherine A Egan; Alicja R Rudnicka

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2283.

ARVO Annual Meeting Abstract June 2023

Longitudinal Analysis of Age-Related Macular Degeneration (AMD) in the AMD Ryan Initiative Study (ARIS)

Jeong W Pak; Gelique Ayala; Cynthia Hurtenbach; Christine Orndahl; Tiarnan D L Keenan; Frederick L Ferris; Traci E Clemons; Emily Y. Chew; Amitha Domalpally

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2177.

ARVO Annual Meeting Abstract June 2022

Consensus Grading of Persistent Hyper-Transmission Defects on En Face OCT Imaging of Age-Related Macular Degeneration

Jeremy Liu; Rita Laiginhas; Federico Corvi; Frederick L Ferris; Tock H Lim; Srinivas R Sadda; Nadia K Waheed; Prashanth G Iyer; Mengxi Shen; Yingying Shi; Omer Trivizki; Liang Wang; Elizabeth Vanner; William J Feuer; Giovanni Gregori; Philip J Rosenfeld

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1029 – F0276.

ARVO Annual Meeting Abstract June 2022

Multimodal Imaging Evaluation of Age-Related Macular Degeneration (AMD) in the AMD Ryan Initiative Study (ARIS)

Andrew Dieu; Cynthia Hurtenbach; Jeong W Pak; Tiarnan D L Keenan; Frederick L Ferris; Charles P Wilkinson; Christine Orndahl; Traci E Clemons; Emily Y Chew; Amitha Domalpally

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1028 – F0275.

ARVO Annual Meeting Abstract June 2022

Visual acuity and full-field stimulus thresholds (FST) over 2 years in the RUSH2A study: annual rates of change from mixed effects modeling

Peiyao Cheng; David G Birch; Jacque L Duncan; Frederick L Ferris; Maureen G Maguire; Allison R. Ayala; Janet K Cheetham; Todd Durham; Abigail T Fahim; Rachel M Huckfeldt; Michel Michaelides; Mark E Pennesi; Jose Alain Sahel; Katarina Stingl; Ajoy Vincent; Christina Y Weng

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4480 – F0267.

Clinical Trials December 2021

Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments

PDF

Jennifer K. Sun; Kristin Josic; Michele Melia; Adam R. Glassman; Clare Bailey; Kakarla V. Chalam; Emily Y. Chew; Catherine Cukras; Sandeep Grover; Glenn J. Jaffe; Richard Lee; Jared S. Nielsen; Darby J. S. Thompson; Henry E. Wiley; Frederick L. Ferris, 3rd; for the DRCR Retina Network
TAGS: diabetic macular edema, eye, optical coherence tomography, sensitivity analysis
Trans. Vis. Sci. Tech.. 2021; 10(14):34. https://doi.org/10.1167/tvst.10.14.34

Includes: Supplemental Content

Perspective April 2021

Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium

PDF

Todd A. Durham; Jacque L. Duncan; Allison R. Ayala; David G. Birch; Janet K. Cheetham; Frederick L. Ferris, III; Carel B. Hoyng; Mark E. Pennesi; José-Alain Sahel; for the Foundation Fighting Blindness Consortium Investigator Group
TAGS: blindness, rare diseases
Trans. Vis. Sci. Tech.. 2021; 10(4):23. https://doi.org/10.1167/tvst.10.4.23

Articles October 2020

The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline

PDF

David G. Birch; Peiyao Cheng; Jacque L. Duncan; Allison R. Ayala; Maureen G. Maguire; Isabelle Audo; Janet K. Cheetham; Todd A. Durham; Abigail T. Fahim; Frederick L. Ferris, III; Elise Heon; Rachel M. Huckfeldt; Alessandro Iannaccone; Naheed W. Khan; Eleonora M. Lad; Michel Michaelides; Mark E. Pennesi; Katarina Stingl; Ajoy Vincent; Christina Y. Weng; for the Foundation Fighting Blindness Consortium Investigator Group
TAGS: electroretinography, visual acuity
Trans. Vis. Sci. Tech.. 2020; 9(11):9. https://doi.org/10.1167/tvst.9.11.9

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Role of Extramacular Drusen in Age-related Macular Degeneration (AMD)

Bohan Xing; Amitha Domalpally; Jeong W Pak; Elvira Agron; Frederick L Ferris; Traci E Clemons; Emily Chew

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3002.

ARVO Annual Meeting Abstract June 2020

Accelerating research in rare inherited retinal disorders (IRDs) through an international consortium

Janet K Cheetham; Allison Ayala; David G Birch; Jacque L Duncan; Todd Durham; Frederick L Ferris; Maureen Maguire; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3356.

ARVO Annual Meeting Abstract June 2020

Baseline visual fields in the RUSH2A study: Associated factors and correlation with measures of disease severity

Jacque L Duncan; Wendi Liang; Isabelle S Audo; David G Birch; Joseph Carroll; Janet K. Cheetham; Laura R Erker; Frederick L Ferris; Elise Heon; Robert Hufnagel; Alessandro Iannaccone; Glenn J Jaffe; Christine N Kay; Maureen Maguire; Michel Michaelides; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3364.

ARVO Annual Meeting Abstract June 2020

Test-retest variability of static perimetry and microperimetry results from the RUSH2A study

Allison Ayala; Wendi Liang; David G Birch; Janet K Cheetham; Elvira N Chegarnov; Jacque L Duncan; Todd Durham; Frederick L Ferris; Eleonora M Lad; Maureen Maguire; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3342.

New Developments in Vision Research April 2019

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

PDF

Ann-Margret Ervin; Rupert W. Strauss; Mohamed I. Ahmed; David Birch; Janet Cheetham; Frederick L. Ferris III; Michael S. Ip; Glenn J. Jaffe; Maureen G. Maguire; Etienne M. Schönbach; SriniVas R. Sadda; Sheila K. West; Hendrik P.N. Scholl; for the ProgStar Study Group
TAGS: atrophy, eye, spectral domain-optical coherence tomography, stargardt's disease, prospective studies
Trans. Vis. Sci. Tech.. 2019; 8(2):16. https://doi.org/10.1167/tvst.8.2.16

ARVO Annual Meeting Abstract July 2018

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration

Katherine Grace Chen; Jason Alvarez; Wai T Wong; Henry Wiley; Emily Y. Chew; Frederick L Ferris; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2423.

ARVO Annual Meeting Abstract July 2018

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Tiarnan D L Keenan; Elvira Agron; Amitha Domalpally; Traci E Clemons; Freekje Van Asten; Wai T Wong; Ronald P Danis; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6010.

ARVO Annual Meeting Abstract July 2018

Development of Geographic Atrophy following Untreated Neovascular Age-related Macular Degeneration—Results from AREDS

Panos George Christakis; Elvira Agron; Michael L Klein; J. Peter Campbell; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4947.

Articles February 2017

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software

PDF

Alex S. Willoughby; Stephanie J. Chiu; Rachel K. Silverman; Sina Farsiu; Clare Bailey; Henry E. Wiley; Frederick L. Ferris, III; Glenn J. Jaffe
TAGS: diabetic macular edema, eye, software
Trans. Vis. Sci. Tech.. 2017; 6(1):9. https://doi.org/10.1167/tvst.6.1.9

Research Opportunities October 2016

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop

PDF

Prashant Nair; Lloyd Paul Aiello; Thomas W. Gardner; Lee M. Jampol; Frederick L. Ferris III
TAGS: diabetic retinopathy, surrogate endpoints, united states food and drug administration, anti-vascular endothelial growth factor therapy, diabetes mellitus, type 2, eye, diabetes mellitus, vision, visual acuity
Invest. Ophthalmol. Vis. Sci.. 2016; 57(13):5127-5142. https://doi.org/10.1167/iovs.16-20356

ARVO Annual Meeting Abstract September 2016

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Juan E Grunwald; Benjamin J Kim; Maureen G Maguire; James A Shaffer; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin; Frederick L Ferris; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2653.

ARVO Annual Meeting Abstract September 2016

Clinical characterization of Ebola-associated eye disease with spectral domain optical coherence tomography

Allen O Eghrari; Rachel Jessica Bishop; Christopher J. Brady; Vincent Ray; Mosoka Fallah; Denise Cunningham; Cavan S Reilly; Frederick L Ferris; Jemma Larbelee

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1668.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Association between diabetic macular edema and mortality independent of retinopathy (R) grade - The North East London Diabetic Eye Screening Programme (DESP) Study

Longitudinal Analysis of Age-Related Macular Degeneration (AMD) in the AMD Ryan Initiative Study (ARIS)

Consensus Grading of Persistent Hyper-Transmission Defects on En Face OCT Imaging of Age-Related Macular Degeneration

Multimodal Imaging Evaluation of Age-Related Macular Degeneration (AMD) in the AMD Ryan Initiative Study (ARIS)

Visual acuity and full-field stimulus thresholds (FST) over 2 years in the RUSH2A study: annual rates of change from mixed effects modeling

Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments

Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium

The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline

Role of Extramacular Drusen in Age-related Macular Degeneration (AMD)

Accelerating research in rare inherited retinal disorders (IRDs) through an international consortium

Baseline visual fields in the RUSH2A study: Associated factors and correlation with measures of disease severity

Test-retest variability of static perimetry and microperimetry results from the RUSH2A study

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Development of Geographic Atrophy following Untreated Neovascular Age-related Macular Degeneration—Results from AREDS

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Clinical characterization of Ebola-associated eye disease with spectral domain optical coherence tomography

To View More...

You must be signed into an individual account to use this feature.